Cardio-adjacent robots, workflow expansions, and device commercialization: this week mixes a new fund backing medtech, a fresh CE mark, and EU market-surveillance tidings.
People on the move
DBV Technologies (Germany)
Kevin Trapp becomes Chief Commercial Officer to prep European go-to-market.
Money flows
United Founders (Luxembourg)
€80M early-stage fund, cheques up to €1M, targeting AI, hardware, dual-use and medtech; early health bet includes Germany’s Every Health. Expect more operator-led tickets into clinical workflows.
Holi (Poland)
€3M Seed; digital obesity clinic. New markets in EU on deck; product build around data-driven care pathway.
On the press
• Nitinotes (Israel) – CE mark for EndoZip, an automated suturing system for endoscopic sleeve gastroplasty; sets up EU commercialization of obesity intervention between drugs and surgery.
• EU #MedSafetyWeek Commission’s health agency Hadea spotlights JAMS 2.0, the joint action strengthening medical device/IVD market surveillance, inspections and data exchange across Member States. Signal: more coordinated enforcement under MDR/IVDR.
• Urteste (Poland) launches European multicenter clinical study of Panuri, an oncology test; another CEE diagnostic attempting EU-wide validation.
One thing to remember
Obesity and imaging drove the week: fresh capital for a Polish digital clinic, a CE-marked automated ESG platform, and a Czech distribution deal show Europe’s buyers want scalable, cost-sensitive interventions. Pair commercialization sprints with the EU’s tighter market-surveillance push to avoid regulatory surprises later.
This content has been enhanced by GenAI.
